Headlands Technologies LLC Makes New Investment in Establishment Labs Holdings Inc. $ESTA

Headlands Technologies LLC purchased a new stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) during the 2nd quarter, HoldingsChannel reports. The fund purchased 13,681 shares of the company’s stock, valued at approximately $1,174,000.

Other large investors have also recently modified their holdings of the company. KBC Group NV bought a new position in shares of Establishment Labs in the first quarter worth approximately $28,000. Quarry LP bought a new stake in Establishment Labs during the third quarter valued at approximately $34,000. Northwestern Mutual Wealth Management Co. purchased a new position in Establishment Labs in the 2nd quarter worth approximately $43,000. Kestra Advisory Services LLC purchased a new position in Establishment Labs in the 4th quarter worth approximately $47,000. Finally, Osaic Holdings Inc. increased its holdings in shares of Establishment Labs by 900.0% in the 2nd quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock worth $85,000 after buying an additional 1,800 shares during the last quarter. Institutional investors own 72.91% of the company’s stock.

Establishment Labs Stock Down 1.9%

Shares of Establishment Labs stock opened at $69.33 on Tuesday. The company’s 50 day moving average price is $84.67 and its 200-day moving average price is $74.92. Establishment Labs Holdings Inc. has a 52-week low of $36.53 and a 52-week high of $97.59. The stock has a market capitalization of $2.07 billion, a price-to-earnings ratio of -52.92 and a beta of 1.07. The company has a debt-to-equity ratio of 12.11, a quick ratio of 2.52 and a current ratio of 3.84.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings data on Thursday, August 6th. The company reported ($0.39) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.05). Establishment Labs had a negative return on equity of 196.69% and a negative net margin of 15.82%.The business had revenue of $67.54 million during the quarter, compared to the consensus estimate of $65.79 million. During the same quarter in the prior year, the business posted ($0.57) earnings per share. Establishment Labs’s quarterly revenue was up 31.7% compared to the same quarter last year. Equities research analysts forecast that Establishment Labs Holdings Inc. will post -1.15 EPS for the current year.

Analyst Upgrades and Downgrades

ESTA has been the topic of several research reports. Needham & Company LLC raised their price objective on shares of Establishment Labs from $86.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Citigroup upgraded shares of Establishment Labs from a “neutral” rating to a “buy” rating and set a $92.00 target price for the company in a research report on Thursday, August 13th. TD Cowen increased their target price on Establishment Labs from $95.00 to $117.00 and gave the company a “buy” rating in a research note on Monday, August 3rd. Canaccord Genuity Group set a $105.00 price objective on Establishment Labs in a report on Thursday, August 6th. Finally, Mizuho upped their price objective on Establishment Labs from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Wednesday, July 15th. Eight investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $100.25.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.